Wittenberg Investment Management, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Wittenberg Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 09, 2024	BUY	$0.14 - $0.24 $7,980 - $13,680	57,000 Added 33.14%	229,000 $48,000
Q2 2023 Aug 11, 2023	BUY	$0.14 - $0.24 $7,980 - $13,680	57,000 Added 33.14%	229,000 $48,000
Q1 2023 Feb 09, 2024	BUY	$0.16 - $0.74 $27,520 - $127,280	172,000 New	172,000 $27,000
Q1 2023 May 15, 2023	BUY	$0.16 - $0.74 $27,520 - $127,280	172,000 New	172,000 $28,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Wittenberg Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Wittenberg Investment Management, Inc. with notifications on news.